<DOC>
	<DOCNO>NCT02683239</DOCNO>
	<brief_summary>Approximately 10,000 patient participate study characterize safety profile fasinumab provide data long-term exposure provide efficacy data . In addition participation main study , approximately 800 patient participate sub-study characterize onset pain relief fasinumab .</brief_summary>
	<brief_title>Long-Term Safety Efficacy Study Fasinumab Patients With Pain Due Osteoarthritis ( OA ) Knee Hip</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Male female ≥18 year age screen visit 2 . Clinical diagnosis OA knee hip base American College Rheumatology criterion radiologic evidence OA ( KL score ≥2 ) index joint screen visit 3 . Moderate severe pain index joint define WOMAC average pain subscale score ≥4 4 . A history inadequate pain relief intolerance analgesic use OA 5 . History regular use analgesic medication OA pain 1 . History presence screen visit non OA inflammatory joint disease History presence image destructive arthropathy neuropathic joint arthropathy , hip dislocation significant bone collapse loss 2 . Patient candidate MRI 3 . Is schedule joint replacement surgery perform study period 4 . Recent systemic ( ie , oral intramuscular ) corticosteroid use 5 . History presence screen visit multiple sclerosis , autonomic neuropathy , diabetic neuropathy , peripheral neuropathy , include reflex sympathetic dystrophy 6 . Evidence autonomic neuropathy define Survey Autonomic Symptoms 7 . History diagnosis chronic autonomic failure syndrome include pure autonomic failure , multiple system atrophy 8 . Pregnant breastfeed woman 9 . Women childbearing potential positive pregnancy test result pregnancy test result baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>